| 标题 |
Safety and efficacy of TQB2102, a novel bispecific anti-HER2 antibody—Drug conjugate, in patients with advanced solid tumors: Preliminary data from the first-inhuman phase 1 trial
新型双特异性抗HER2抗体—药物偶联物TQB2102在晚期实体瘤患者中的安全性和疗效:首次非人1期试验的初步数据
|
| 网址 | |
| DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |